Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

FRA/HUM stock hub

FRA/HUM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/HUMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/HUM

In the news

Latest news · FRA/HUM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.5

P25 n/aP50 n/aP75 n/a

Trailing P/E28.6

P25 n/aP50 n/aP75 n/a

ROE6.3

P25 n/aP50 n/aP75 n/a

ROIC8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/HUM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	67,060
Employees Change	-1,920%
Employees Change Percent	-2.84
Enterprise value	EUR 36.1B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Hospital and Medical Service Plans
Last refreshed	2026-05-10
Market cap	EUR 28B
Price	EUR 222
Price currency	EUR
Rev Per Employee	1,774,434.24x
Sic	6324
Symbol	fra/HUM
Website	https://www.humana.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.49%
EV Earnings	36.84x
EV/EBIT	14.07x
EV/EBITDA	12.21x
EV/FCF	32.73x
EV/Sales	0.31x
FCF yield	3.93%
Forward P/E	25.52x
P/B ratio	1.73x
P/E ratio	28.62x
P/S ratio	0.24x
PE Ratio10 Y	21.19x
PE Ratio3 Y	22.15x
PE Ratio5 Y	21.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.26%
EBITDA Margin	2.45%
FCF margin	0.93%
Gross margin	14.01%
Gross Profit	EUR 16.7B
Net Income	EUR 980M
Net Income Growth	-33.92%
Net Income Growth Q	-4.66%
Net Income Growth3 Y	-28.68%
Net Income Growth5 Y	-21.21%
Pretax Margin	1.01%
Profit Margin	0.82%
Profit Per Employee	EUR 14,615
ROA	3.64
Roa5y	5.16
ROCE	9.16
ROE	6.28
Roe5y	13.52
ROIC	8
Roic5y	10.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.75%
Cagr15y	11.28%
Cagr1y	1.82%
Cagr20y	10.75%
Cagr3y	-22.21%
Cagr5y	-9.51%
Div CAGR10	11.28%
Div CAGR3	-0.97%
Div CAGR5	6.64%
EPS Growth	-33.91
EPS Growth Q	-4.56
EPS Growth3 Y	-27.55
EPS Growth5 Y	-19.77
FCF Growth	-46.58%
FCF Growth Q	380.09%
FCF Growth3 Y	-49.55%
FCF Growth5 Y	-17.19%
OCF Growth	-35.84%
OCF Growth Q	278.85%
OCF Growth10 Y	3.86%
OCF Growth3 Y	-44.81%
OCF Growth5 Y	-15.69%
Revenue Growth	14.08x
Revenue Growth Q	23.47x
Revenue Growth3 Y	12.78x
Revenue Growth5 Y	11.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 2.58
Assets	EUR 47.9B
Cash	EUR 19.1B
Debt	EUR 12.5B
Debt EBITDA	EUR 4.04
Debt Equity	EUR 0.77
Debt FCF	EUR 11.3
Equity	EUR 16.2B
Interest Coverage	4.66
Liabilities	EUR 31.8B
Net Cash	EUR -8.2B
Net Cash By Market Cap	EUR -29.13
Net Debt EBITDA	EUR 2.8
Net Debt Equity	EUR 0.51
Net Debt FCF	EUR 7.41
Tangible Book Value	EUR 6B
Tangible Book Value Per Share	EUR 49.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Net Working Capital	EUR 11.8B
Quick ratio	1.26
Working Capital	EUR 14.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.01%
Dividend Growth	-7.87%
Dividend Growth Years	0%
Dividend per share	EUR 3.03
Dividend Years	16
Dividend Yield	1.37%
Ex Div Date	2026-03-27
Last Dividend	EUR 0.77
Payout Frequency	Quarterly
Payout Ratio	37.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	59.04%
1Y total return	1.82%
200-day SMA	206
3Y total return	-52.93%
50-day SMA	166.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.31%
All Time High	584.8
All Time High Change	-62.04%
All Time High Date	2022-11-03
All Time Low	5
All Time Low Change	4,340%
All Time Low Date	2000-06-09
ATR	7.39
Ch YTD	1.79
High	222
High52	269.5
High52 Date	2025-09-02
High52ch	-17.63%
Low	210
Low52	142
Low52 Date	2026-03-12
Low52ch	56.34%
Ma50ch	33.06%
Price vs 200-day SMA	7.74%
RSI	85.48
RSI Monthly	47.46
RSI Weekly	62.08
Sharpe ratio	0.27x
Sortino ratio	0.48
Total Return	1.35%
Tr YTD	2.31
Tr15y	397.18%
Tr1m	31.36%
Tr1w	9.9%
Tr3m	36.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.7B
Operating margin	2.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	119,752,401%
Net Borrowing	543,543,642
Shares Insiders	0.13%
Shares Institutions	102.98%
Shares Qo Q	0.26%
Shares Yo Y	0.01%
Short Ratio	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 892.5M
Average Volume	5.8x
Bv Per Share	134.2
CAPEX	EUR -496.1M
Ch10y	46.17
Ch15y	333.8
Ch1m	31.36
Ch1w	9.9
Ch1y	0.23
Ch20y	572.7
Ch3m	35.45
Ch3y	-54.6
Ch5y	-42.25
Ch6m	2.12
Change	6.73%
Change From Open	5.71
Close	208
Days Gap	0.96
Earnings Date	2026-04-29
EBIT	EUR 2.7B
EBITDA	EUR 2.9B
EPS	EUR 8.12
F Score	6
FCF	EUR 1.1B
FCF EV Yield	3.06x
Financing CF	-476,147,700
Fiscal Year End	December
Founded	1,961
Goodwill	8,894,273,418
Graham Number	149.47131
Graham Upside	-32.67
Income Tax	EUR 207.3M
Investing CF	-515,176,200
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	EUR 38.79
Lynch Upside	-82.53
Ma150	197.2
Ma150ch	12.59%
Ma20	188.7
Ma20ch	17.65%
Net CF	607,977,300
Next Earnings Date	2026-07-29
Open	210
P FCF Ratio	25.42
P OCF Ratio	17.54
Payment Date	2026-04-24
Position In Range	100
Ppne	1,840,077,540
Price Date	2026-05-08
Price EBITDA	EUR 9.62
Ptbv Ratio	4.68
Relative Volume	15.9x
Revenue	118,993,560,000x
SBC By Revenue	0.18x
Share Based Comp	210,753,900
Tax By Revenue	0.17x
Tax Rate	17.27%
Tr20y	671.08%
Tr6m	3%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/HUM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$3.03 annual per share

Payout ratio

+38.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.6%

0 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2026-03-27

Performance

FRA/HUM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/HUM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+103.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/HUM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

85.5

Above 70: short-term overbought

Price vs 200-day MA

+7.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/HUM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/HUM stock rating?

fra/HUM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/HUM analysis?

The full report lives at /stocks/fra/HUM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/HUM?

The latest report frames fra/HUM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/HUM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.